FDA approves Novartis drug to treat pain crises in sickle cell disease

  Novartis announced late Friday that the Food and Drug Administration has approved Adakveo — formerly called SEG101 — to reduce the frequency of vaso-occlusive crises (VOCs), or...

Verma attacks critics of Medicaid work requirement, pushes for tighter eligibility

Seema Verma, the Trump administration’s top Medicaid official, Tuesday sharply attacked critics of her plan to force some Medicaid enrollees to work, a policy that led...

Opinion: Brexit and its impact on healthcare – What is happening now?

After several decades of EU membership, UK and EU co-operation in many mutually beneficial areas is strong, underpinned by European legislation and infrastructure such as shared...

Bruising labor battles put Kaiser Permanente’s reputation on the line

Kaiser Permanente, which just narrowly averted one massive strike, is facing another one Monday. The ongoing labor battles have undermined the health giant’s once-golden reputation as a...

If you want your patients to take their meds, ensure they can afford what...

How many times do you think this happens? After thoughtful deliberation and discussion, a physician prescribes a medication that they think will be a good option...

Employers are scaling back their dependence on high-deductible health plans

Everything old is new again. As open enrollment gets underway for next year’s job-based health insurance coverage, some employees are seeing traditional plans offered alongside or...

Beam Therapeutics in-licenses ‘efficient’ single-letter genome editing tech

A company working on a form of gene-editing technology that would allow editing at the single-letter level has formed a licensing deal with another company started...

How to improve your care team? Enlist the help of a pharmacist.

As the nation’s population ages, our medication regimens grow. Government sources cite that 42 percent  of American adults take five or more medications – this is...

Azitra brings in Series A to advance microbiome skin therapies

Connecticut-based microbiome therapy company Azitra recently announced a $14 million haul in Series A funding. The round was led by KdT Ventures and previous investor Bios Partners,...

Whistleblower alleges Medicare fraud at iconic Seattle-based health plan

Group Health Cooperative in Seattle, one of the nation’s oldest and most respected nonprofit health insurance plans, is accused of bilking Medicare out of millions of...

Must Read